LOS ANGELES -- Patients with metastatic melanoma have faced grim prospects: the American cancer society says the five-year survival rate is only 15 percent. That started changing when the FDA approved ...
Add Yahoo as a preferred source to see more of our stories on Google. Platinum-resistant ovarian cancer (PROC) remains one of the most treatment-refractory malignancies, with a median overall survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results